ISSN: 2161-1149 (Printed)
+44-77-2385-9429
Amit P. Ladani
The rheumatology community has been confronted with many challenges during the COVID-19 pandemic. Early in the pandemic, there were questions about managing rheumatic immunosuppressive medications, while of late, it has been about the COVID-19 vaccine. As the pandemic continues to evolve, and more high-quality studies are available to answer pressing questions, many unknowns remain. This summary attempts to provide a viewpoint from a Rheumatologists’ angle about the current landscape of COVID-19.
Published Date: 2020-12-29; Received Date: 2020-12-08